CINC   $29.06  -0.41% Market Closed

CinCor Pharma Inc
Last Events:

2023-03-29 Trend pattern changed from расходящийся клин с наклоном вниз to сужающийся канал.

2023-03-29 Signal in Stochastic changed from bullish to bullish recovery. The stochastic indicator is in the upper part of the neutral territory and it heading north. These factors indicate that positive dynamics is recovering. Last signal: main and signal line crossing.

2023-03-29 Signal in MACD changed from bullish reversal to bearish reversal. Oscillator MACD is in the positive territory it's lower than the signal line and falls. These factors mean that the growing period is over. Last signal: exit from the overbought zone.

2023-03-29 Signal in RSI changed from bullish to bullish recovery. RSI indicator is in overbought territory and it grows. These factors indicate that the upside potential still holds even though the market is overbought. Last signal: entrance to the overbought zone.

2023-03-29 Trend pattern changed from сужающийся канал to расходящийся клин с наклоном вниз.

2023-03-29 Signal in Stochastic changed from bullish recovery to bullish. The stochastic indicator is in the upper part of the neutral territory and it heading north. These factors indicate that positive dynamics is recovering. Last signal: signal line crossed the middle level.

2023-03-29 Signal in MACD changed from bearish reversal to bullish reversal. Oscillator MACD is in the negative territory it's higher than the signal line and grows. These factors mean that the falling period is over. Last signal: exit from the oversold zone.

2023-03-29 Signal in RSI changed from bullish recovery to bullish. RSI indicator is in overbought territory and it grows. These factors indicate that the upside potential still holds even though the market is overbought. Last signal: entrance to the overbought zone.


Current temperature: 0.58
ST: 0, Cor:

50-50 Year Forecast
Low with 50% probability: 15.82
Target: 41.00
High with 50% probability: 45.07
Analyst Recommendations:
Number of estimates 4
Target Price Mean 41.00
Mean unverified/preliminary 41.00 / 41.00
Target Price Low / High 30.00 / 53.00
Median / STD DEV 40.50 / 12.19
Tech Forecasts:
More signals
  < 1M 1-3M > 3M
total - - Sell
rsi Sell Sell Sell
macd ActivelyBuy Buy -
stoch - - -
ma20 - - -
ma50 - - -
ma100 - - -
Candlestick PatternFeb. 23, 2023 Doji - is formed when the open and the close are the same or very close. The body of candle is small. The length of the shadows are not important. The appearance of a Doji should alert the investor of major indecision.
ISIN US17240Y1091
ceo Mr. Marc M. P. de Garidel
Website https://www.cincor.com
CinCor Pharma, Inc., a clinical-stage biopharmaceutical company, engages in the development of drugs for the treatment for cardio-renal diseases. It is involved in developing CIN-107, which is in Phase II clinical trial for the treatment of hypertension, primary aldosteronism, and other cardio-renal diseases, as well as in Phase I clinical trial to treat chronic kidney diseases. The company was incorporated in 2018 and is based in Waltham, Massachusetts. As of February 23, 2023, CinCor Pharma, Inc. operates as a subsidiary of AstraZeneca Finance and Holdings Inc..